← Back to headlines
Lilly's Valuation Reflects Lower Growth Expectations
An analysis suggests that the current valuation multiple for pharmaceutical company Lilly implies a lower growth trajectory than commonly perceived by investors.
21 Aug, 18:40 — 21 Aug, 18:40
Sources
Showing 1 of 1 sources
Related Stories
TWG Global Denies Fraud Allegations Amid Ongoing Federal Investigation
14m ago
Bill Gates Warns of Unprepared World as He Proposes New AI Safeguards
18m ago
U.S. inflation rises again and stays well above Fed’s target. Rate hike might be in play.
19m ago
US Core Inflation Holds at 3.3% in July Amid Persistent Energy Costs
23m ago